Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vital Connect Makes Play With Clinical-Grade Biosensor

This article was originally published in The Gray Sheet

Executive Summary

The firm expects FDA clearance for its HealthPatch MD sensor in the next few months – an important step in its plan to make remote patient monitoring more convenient, accessible and affordable. The small, adhesive device can act as an electrocardiogram while also recording heart rate and its features, respiratory rate and other measures.

You may also be interested in...



Wearable Fitness Technology Could Foretell The Future Of Remote Patient Monitoring

Wearable wireless monitoring devices geared toward the fitness market are beginning to attract the attention of the health care industry, which recognizes the technology’s potential to provide an ideal patient monitoring tool. As more of this technology makes its way into the clinical setting, this trend is poised to change the traditional view of what is and is not a medical device.

Digital Health Briefs: Apple Hires Medical Sensor Experts; Glooko Partnership

Apple hires medical sensor talent. Glooko partners with Joplin Diabetes Center. NIH director praises ZioPatch study. More digital health news.

Darzalex Surpasses Stelara As J&J’s Best-Selling Drug

Sales of Stelara are expected to begin tapering off later this year when the first biosimilars launch in mid-2024 in Europe and later in the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033566

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel